Scheffler Jonas, Liebau Arne, Lehner Eric, Leisz Sandra, Koitzsch Sabine, Reiber Julia, Harder Anja, Plontke Stefan K
Department of Otorhinolaryngology, Head & Neck Surgery, University Medicine Halle, Halle (Saale), Germany.
Department of Otorhinolaryngology, Head & Neck Surgery, University Medicine Halle, Halle (Saale), Germany.
J Neurosci Methods. 2025 Oct;422:110515. doi: 10.1016/j.jneumeth.2025.110515. Epub 2025 Jun 17.
Vestibulocochlear schwannomas (VS) are benign tumors arising from Schwann cells of the eighth cranial nerve. While VS are commonly located in the internal auditory canal (IAC) or cerebellopontine angle (CPA), a subset occurs within the inner ear, known as inner ear schwannomas (IES). Their location influences management strategies in terms of tumor control, hearing, and vestibular function. Despite the differences between IES and CPA- or IAC-located VS with respect to epidemiology, anatomical pathology, growth behavior, and clinical management, little is known about biological characteristics of IES.
We developed a reliable technique for isolation of primary tumor cells from ten IES samples for a standardized application. Cells were isolated, processed and cultured for 28 days. Four samples were further characterized by assessing morphology and stability of schwannoma cells as well as presence of monocytic cells.
In all samples, primary cells were successfully cultured and expanded for at least 28 days. Sequential imaging showed characteristic schwannoma cell morphology and a stable growth pattern.
While existing protocols had focused on establishing primary cultures of VS in the CPA/IAC so far, this study presents the first successful establishment of primary IES cell cultures from different locations within the inner ear.
This work is intended as a proof-of-principle to provide a valuable in vitro model system for investigating biological properties of IES, allowing expansion of small samples of a rare schwannoma subtype and in vitro analysis of new therapeutic approaches.
前庭蜗神经鞘瘤(VS)是起源于第八对脑神经施万细胞的良性肿瘤。虽然VS通常位于内耳道(IAC)或桥小脑角(CPA),但有一部分发生在内耳,称为内耳神经鞘瘤(IES)。它们的位置在肿瘤控制、听力和前庭功能方面影响治疗策略。尽管IES与位于CPA或IAC的VS在流行病学、解剖病理学、生长行为和临床管理方面存在差异,但关于IES的生物学特性知之甚少。
我们开发了一种可靠的技术,用于从10个IES样本中分离原代肿瘤细胞,以实现标准化应用。细胞被分离、处理并培养28天。通过评估神经鞘瘤细胞的形态和稳定性以及单核细胞的存在,对4个样本进行了进一步表征。
在所有样本中,原代细胞均成功培养并扩增至少28天。连续成像显示出典型的神经鞘瘤细胞形态和稳定的生长模式。
虽然目前现有的方案主要集中在建立CPA/IAC中VS的原代培养,但本研究首次成功地从内耳不同位置建立了IES原代细胞培养。
这项工作旨在作为原理验证,为研究IES的生物学特性提供一个有价值的体外模型系统,允许扩增罕见神经鞘瘤亚型的小样本,并对新的治疗方法进行体外分析。